• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞模型的演变。

Evolution of the cancer stem cell model.

机构信息

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

出版信息

Cell Stem Cell. 2014 Mar 6;14(3):275-91. doi: 10.1016/j.stem.2014.02.006.

DOI:10.1016/j.stem.2014.02.006
PMID:24607403
Abstract

Genetic analyses have shaped much of our understanding of cancer. However, it is becoming increasingly clear that cancer cells display features of normal tissue organization, where cancer stem cells (CSCs) can drive tumor growth. Although often considered as mutually exclusive models to describe tumor heterogeneity, we propose that the genetic and CSC models of cancer can be harmonized by considering the role of genetic diversity and nongenetic influences in contributing to tumor heterogeneity. We offer an approach to integrating CSCs and cancer genetic data that will guide the field in interpreting past observations and designing future studies.

摘要

遗传分析已经极大地塑造了我们对于癌症的理解。然而,越来越明显的是,癌细胞表现出正常组织的特征,而癌症干细胞(CSC)能够驱动肿瘤生长。尽管通常被认为是描述肿瘤异质性的相互排斥的模型,但我们提出,通过考虑遗传多样性和非遗传因素在促成肿瘤异质性方面的作用,可以协调癌症的遗传和 CSC 模型。我们提供了一种整合 CSC 和癌症遗传数据的方法,该方法将指导该领域解释过去的观察结果并设计未来的研究。

相似文献

1
Evolution of the cancer stem cell model.癌症干细胞模型的演变。
Cell Stem Cell. 2014 Mar 6;14(3):275-91. doi: 10.1016/j.stem.2014.02.006.
2
Intra-tumor heterogeneity from a cancer stem cell perspective.从癌症干细胞角度看肿瘤内异质性。
Mol Cancer. 2017 Feb 16;16(1):41. doi: 10.1186/s12943-017-0600-4.
3
Overview: Cancer Stem Cell and Tumor Environment.综述:癌症干细胞与肿瘤微环境。
Oncology. 2015;89 Suppl 1:22-4. doi: 10.1159/000431060. Epub 2015 Nov 10.
4
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.癌症干细胞异质性:起源及针对癌症干细胞的新观点
BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222.
5
Stem cell programs in cancer initiation, progression, and therapy resistance.肿瘤起始、进展和治疗抵抗中的干细胞程序。
Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020.
6
Cancer stem cells: understanding tumor hierarchy and heterogeneity.癌症干细胞:理解肿瘤层级结构与异质性
Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S2-S7. doi: 10.1097/MD.0000000000004764.
7
Cancer stem cells: a guide for skeptics.癌症干细胞:怀疑者指南
J Cell Biochem. 2009 Apr 1;106(5):745-9. doi: 10.1002/jcb.22050.
8
Cancer stem cells and angiogenesis.癌症干细胞与血管生成。
Int J Dev Biol. 2011;55(4-5):477-82. doi: 10.1387/ijdb.103225yz.
9
Cancer stem cells: A brief review of the current status.癌症干细胞:当前现状简述。
Gene. 2019 Jan 10;681:80-85. doi: 10.1016/j.gene.2018.09.052. Epub 2018 Sep 27.
10
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.癌症干细胞(CSCs):鉴定和消除它们的代谢策略。
Biochem J. 2018 May 9;475(9):1611-1634. doi: 10.1042/BCJ20170164.

引用本文的文献

1
PPIL1 Drives Hepatocellular Carcinoma Progression and Cancer Stem Cell Self-renewal Through DAAM2-mediated Wnt/β-Catenin Activation.PPIL1通过DAAM2介导的Wnt/β-连环蛋白激活驱动肝细胞癌进展和癌症干细胞自我更新。
Cancer Genomics Proteomics. 2025 Sep-Oct;22(5):760-774. doi: 10.21873/cgp.20535.
2
The Role of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Cancer Stem Cell Signaling.受体酪氨酸激酶样孤儿受体1(ROR1)在癌症干细胞信号传导中的作用
Int J Mol Sci. 2025 Aug 13;26(16):7828. doi: 10.3390/ijms26167828.
3
Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies.
应对黑色素瘤放射抗性:机制与治疗策略
Cancers (Basel). 2025 Aug 14;17(16):2648. doi: 10.3390/cancers17162648.
4
Haematopoietic stem cell number is not solely defined by niche availability.造血干细胞数量并非仅由龛位可用性决定。
Nature. 2025 Aug 27. doi: 10.1038/s41586-025-09462-5.
5
Targeting the roots of myeloid malignancies with T cell receptors.利用T细胞受体靶向髓系恶性肿瘤的根源。
Nat Rev Cancer. 2025 Aug 21. doi: 10.1038/s41568-025-00857-0.
6
Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities.个性化治疗中的癌症干细胞:机制、微环境相互作用及治疗弱点
Front Cell Dev Biol. 2025 Jul 30;13:1619597. doi: 10.3389/fcell.2025.1619597. eCollection 2025.
7
Cancer Stem Cells in Melanoma: Drivers of Tumor Plasticity and Emerging Therapeutic Strategies.黑色素瘤中的癌症干细胞:肿瘤可塑性的驱动因素及新兴治疗策略
Int J Mol Sci. 2025 Aug 1;26(15):7419. doi: 10.3390/ijms26157419.
8
The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy.肿瘤起始细胞在消化系统肿瘤中的免疫调节作用:从机制到治疗
Front Immunol. 2025 Jul 24;16:1621464. doi: 10.3389/fimmu.2025.1621464. eCollection 2025.
9
The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer.LRP4/YAP轴驱动乳腺癌中的耐辐射持久性(RTP)细胞状态。
Theranostics. 2025 Jun 23;15(15):7528-7544. doi: 10.7150/thno.101393. eCollection 2025.
10
Joint representation and visualization of derailed cell states with Decipher.使用Decipher对脱轨细胞状态进行联合表示和可视化。
Genome Biol. 2025 Jul 23;26(1):219. doi: 10.1186/s13059-025-03682-8.